Stock listing
TPEx:6621 Unipharma Co., Ltd. (華宇藥) 股價
Follow Unipharma Co., Ltd. into a list and get an email when it puts out news.
Share price · TPEX:6621
$10.95 TWD -1.10 (-9.1%)
Close on Nov 20, 2026
- Day range
- $10.20 – $10.95 TWDNov 20, 2026
- Volume
- 95,430 sharesNov 20, 2026
- Market cap
- $388.7M TWDAt the close on Nov 20, 2026 · price × 35.50M shares outstanding
- Traded on an average day
- $651,667 TWDMedian day 40,066 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6621 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.95 | -1.10 | -9.1% | $10.90 | $10.95 | $10.20 | 95,430 | |
| $12.05 | -0.10 | -0.8% | $12.15 | $12.15 | $12.00 | 33,010 | |
| $12.15 | +0.15 | +1.3% | $12.20 | $12.20 | $11.85 | 6,021 | |
| $12.00 | -0.30 | -2.4% | $12.05 | $12.45 | $11.95 | 55,018 | |
| $12.30 | -0.15 | -1.2% | $12.45 | $12.50 | $12.05 | 61,015 | |
| $12.45 | +0.45 | +3.7% | $12.20 | $12.45 | $11.95 | 35,010 | |
| $12.00 | -0.15 | -1.2% | $12.25 | $12.25 | $11.95 | 70,008 | |
| $12.15 | -0.05 | -0.4% | $12.20 | $12.25 | $12.15 | 12,908 | |
| $12.20 | +0.20 | +1.7% | $11.85 | $12.20 | $11.85 | 1,104 | |
| $12.00 | -0.65 | -5.1% | $12.25 | $12.25 | $11.65 | 60,528 | |
| $12.65 | +0.30 | +2.4% | $12.50 | $12.65 | $12.20 | 37,739 | |
| $12.35 | -0.15 | -1.2% | $12.55 | $12.55 | $12.25 | 70,104 | |
| $12.50 | +0.05 | +0.4% | $12.55 | $12.70 | $12.35 | 65,016 | |
| $12.45 | -0.15 | -1.2% | $12.70 | $12.70 | $12.45 | 26,069 | |
| $12.60 | +0.15 | +1.2% | $12.45 | $12.65 | $12.25 | 182,511 | |
| $12.45 | -0.10 | -0.8% | $12.65 | $12.65 | $12.30 | 193,619 | |
| $12.55 | +0.50 | +4.1% | $12.05 | $12.65 | $11.95 | 148,086 | |
| $12.05 | +0.50 | +4.3% | $11.55 | $12.05 | $11.50 | 99,674 | |
| $11.55 | 0.00 | 0.0% | $11.55 | $11.55 | $11.55 | 0 | |
| $11.55 | +0.50 | +4.5% | $11.05 | $11.55 | $11.00 | 77,739 | |
| $11.05 | -0.25 | -2.2% | $11.55 | $11.55 | $11.05 | 23,114 | |
| $11.30 | -0.55 | -4.6% | $11.50 | $11.70 | $10.50 | 178,219 | |
| $11.85 | -0.05 | -0.4% | $11.90 | $11.90 | $11.50 | 29,319 | |
| $11.90 | -0.20 | -1.7% | $12.10 | $12.10 | $11.50 | 19,713 | |
| $12.10 | +0.10 | +0.8% | $12.05 | $12.10 | $11.70 | 7,009 | |
| $12.00 | -0.20 | -1.6% | $12.05 | $12.20 | $11.60 | 36,307 | |
| $12.20 | 0.00 | 0.0% | $12.05 | $12.60 | $12.05 | 22,225 | |
| $12.20 | -0.40 | -3.2% | $12.65 | $12.65 | $12.05 | 22,029 | |
| $12.60 | +0.40 | +3.3% | $12.60 | $12.60 | $12.20 | 6,097 | |
| $12.20 | -0.30 | -2.4% | $12.65 | $12.65 | $12.15 | 33,415 | |
| $12.50 | +0.20 | +1.6% | $12.50 | $12.50 | $12.10 | 72,016 | |
| $12.30 | -0.10 | -0.8% | $12.55 | $12.55 | $11.95 | 55,129 | |
| $12.40 | +0.05 | +0.4% | $12.35 | $12.40 | $11.95 | 9,031 | |
| $12.35 | -0.20 | -1.6% | $12.55 | $12.55 | $12.20 | 54,008 | |
| $12.55 | -0.05 | -0.4% | $12.60 | $12.60 | $12.35 | 143,336 | |
| $12.60 | +0.70 | +5.9% | $12.05 | $12.60 | $12.05 | 158,048 | |
| $11.90 | -0.05 | -0.4% | $12.10 | $12.10 | $11.80 | 114,825 | |
| $11.95 | +0.40 | +3.5% | $11.85 | $11.95 | $11.65 | 72,368 | |
| $11.55 | +0.05 | +0.4% | $11.80 | $11.85 | $11.50 | 30,559 | |
| $11.50 | +0.10 | +0.9% | $11.60 | $11.60 | $11.45 | 40,008 | |
| $11.40 | 0.00 | 0.0% | $11.60 | $11.60 | $11.30 | 56,113 | |
| $11.40 | -0.15 | -1.3% | $11.15 | $11.50 | $11.15 | 95,011 | |
| $11.55 | +0.05 | +0.4% | $11.50 | $11.55 | $11.15 | 21,318 | |
| $11.50 | 0.00 | 0.0% | $11.50 | $11.50 | $11.20 | 8,009 | |
| $11.50 | -0.05 | -0.4% | $11.30 | $11.50 | $11.20 | 40,124 | |
| $11.55 | -0.05 | -0.4% | $11.20 | $11.55 | $11.20 | 10,171 | |
| $11.60 | 0.00 | 0.0% | $11.60 | $11.65 | $11.20 | 37,007 | |
| $11.60 | +0.40 | +3.6% | $11.45 | $11.60 | $11.20 | 64,542 | |
| $11.20 | -0.25 | -2.2% | $11.15 | $11.70 | $11.15 | 52,018 | |
| $11.45 | +0.25 | +2.2% | $11.15 | $11.45 | $11.10 | 76,066 | |
| $11.20 | -0.25 | -2.2% | $11.45 | $11.45 | $10.95 | 50,806 | |
| $11.45 | +0.15 | +1.3% | $11.45 | $11.45 | $11.00 | 2,012 | |
| $11.30 | 0.00 | 0.0% | $10.95 | $11.30 | $10.95 | 21,004 | |
| $11.30 | -0.05 | -0.4% | $11.45 | $11.45 | $10.90 | 29,015 | |
| $11.35 | -0.10 | -0.9% | $11.45 | $11.45 | $11.10 | 63,018 | |
| $11.45 | +0.35 | +3.2% | $11.15 | $11.50 | $11.10 | 30,508 | |
| $11.10 | 0.00 | 0.0% | $11.55 | $11.55 | $11.05 | 41,229 | |
| $11.10 | -0.40 | -3.5% | $11.55 | $11.55 | $11.10 | 98,313 | |
| $11.50 | 0.00 | 0.0% | $11.55 | $11.55 | $11.15 | 15,009 | |
| $11.50 | -0.05 | -0.4% | $11.60 | $11.60 | $11.15 | 2,018 | |
| $11.55 | 0.00 | 0.0% | $11.55 | $11.55 | $11.00 | 80,033 | |
| $11.55 | -0.10 | -0.9% | $11.65 | $11.65 | $11.15 | 35,114 |
- Ticker
- TPEx:6621
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- TPEx
- Currency
- TWD
Latest news
Unipharma Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 1 in the last 12 months · 1 in all · newest Feb 12, 2026 · oldest 2026
Valuation
EV/sales 3.2× against a median of 1.1×: 8th lowest of 11 Health care services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $281.1M TWD
- P/E
- Loss
- EV/sales
- 3.2×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.0×
- Gross margin
- 53.4%
- Operating margin
- −49.9%
- Net margin
- −45.8%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Unipharma Co., Ltd. · TPEX:6621 | US$11.79M | US$8.53M | n/a | 3.2× | n/a | 2.0× | −45.8% | 0.0× | n/a |
| Beamtree Holdings Ltd · ASX:BMT | US$12.71M | US$13.72M | n/a | 0.7× | 149× | 0.8× | −62.6% | 0.2× | n/a |
| Genesis Fertility Center Public Company Limited · SET:GFC | US$12.70M | US$9.80M | 19.3× | 0.9× | 4.0× | 0.8× | 6.3% | 0.0× | n/a |
| Talius Group Limited · ASX:TAL | US$12.55M | US$9.78M | n/a | 1.9× | n/a | 3.1× | −19.1% | 0.1× | n/a |
| Mukdahan International Hospital Public Company Limited · SET:HANN | US$12.20M | US$9.07M | 66.8× | 0.7× | 6.3× | 1.4× | 1.4% | 0.1× | n/a |
| Alzai Health Corp. · TSXV:ALZI | US$11.86M | US$10.93M | n/a | 227× | n/a | 11.2× | n/a | 0.4× | n/a |
| Eukedos SpA · MIL:EUK | US$11.73M | US$11.27M | n/a | 0.2× | 1.2× | 0.4× | −1.4% | 0.0× | n/a |
| ImExHS Ltd · ASX:IME | US$11.16M | US$10.15M | n/a | 0.5× | 10.1× | 1.0× | −10.0% | 0.0× | n/a |
| Intrasense SA · EURONEXT:ALINS | US$11.00M | US$10.61M | n/a | 3.3× | n/a | n/a | −364.8% | n/a | n/a |
| iTonic Holdings Ltd · NASDAQ:ITOC | US$10.87M | US$8.90M | n/a | 17.0× | n/a | 0.5× | −974.7% | 0.0× | 1.06 |
| Republic Healthcare Limited · HKEX:8357 | US$10.83M | US$9.29M | n/a | 1.2× | n/a | 1.8× | −40.3% | 0.4× | n/a |
| Median of the others | US$11.79M | US$9.98M | 43.0× | 1.1× | 6.3× | 1.0× | −19.1% | 0.1× | 1.06 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 88.4M | 93.5M | 103.2M | 128.1M | 105.4M | 138.6M | 154.3M |
| Cost of revenue | 41.2M | 44.7M | 52.2M | 53.5M | 46.1M | 69.3M | 80.5M |
| Gross profit | 47.2M | 48.7M | 51.0M | 74.6M | 59.3M | 69.3M | 73.8M |
| Research and development | 22.8M | 16.6M | 17.8M | 26.3M | 33.0M | 24.9M | 34.8M |
| Selling, general and administrative | 68.5M | 22.8M | 19.9M | 20.3M | 30.3M | 22.0M | 20.2M |
| Operating income | -44.1M | -30.8M | -27.3M | -20.9M | -40.2M | -20.6M | -27.8M |
| Depreciation and amortization | 7.00M | 7.00M | 5.54M | 5.53M | 10.8M | 11.2M | 11.1M |
| EBITDA | -37.1M | -23.8M | -21.8M | -15.3M | -29.4M | -9.44M | -16.7M |
| Interest expense | 99.0K | 108.0K | 14.0K | 39.0K | 99.0K | 141.0K | 163.0K |
| Income before tax | -40.5M | -24.8M | -21.8M | -7.03M | -74.4M | -55.4M | -25.0M |
| Net income | -40.5M | -24.8M | -21.8M | -6.45M | -74.4M | -55.4M | -25.0M |
| Earnings per share, basic | -1.14 | -0.70 | -0.61 | -0.18 | -2.11 | -1.57 | -0.71 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 29.0M | 58.7M | 68.6M | 63.8M | 76.0M | 74.6M | 200.5M |
| Short-term investments | 106.4M | 98.5M | 98.5M | 98.5M | 99.5M | 113.5M | |
| Receivables | 14.7M | 16.9M | 21.2M | 34.1M | 23.0M | 24.2M | 25.3M |
| Inventory | 31.3M | 22.3M | 28.9M | 31.0M | 35.9M | 25.7M | 26.0M |
| Current assets | 184.5M | 200.0M | 226.2M | 238.3M | 261.4M | 241.4M | 256.3M |
| Total assets | 275.0M | 329.0M | 350.1M | 332.6M | 348.2M | 415.6M | 456.1M |
| Accounts payable | 18.0M | 14.5M | 22.2M | 6.09M | 27.7M | 2.22M | 10.5M |
| Current liabilities | 37.9M | 33.2M | 37.1M | 28.8M | 46.8M | 25.1M | 37.9M |
| Total debt | 14.8M | 277.0K | 3.53M | 6.99M | 16.8M | 22.4M | |
| Total liabilities | 45.2M | 44.2M | 37.4M | 29.3M | 50.6M | 36.6M | 54.9M |
| Shareholders' equity | 229.8M | 284.8M | 312.7M | 303.2M | 297.6M | 379.0M | 401.2M |
| Shares outstanding | 35.5M | 35.5M | 35.5M | 35.5M | 35.2M | 35.2M | 35.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -36.7M | -14.3M | 12.0M | -31.7M | -12.9M | -17.2M | -9.24M |
| Capital spending | -1.88M | -2.84M | -8.11M | -435.0K | -3.21M | -638.0K | -283.0K |
| Free cash flow | -38.6M | -17.2M | 3.92M | -32.1M | -16.1M | -17.8M | -9.52M |
| Cash from investing | 8.18M | -3.89M | -1.12M | 19.8M | 31.9M | 1.93M | |
| Cash from financing | -3.83M | -3.26M | 20.6M | -5.49M | -5.57M | -8.13M | |
| Share buybacks | -2.76M | ||||||
| Change in cash | -29.7M | -9.97M | 4.89M | -12.2M | 1.37M | 9.11M | -15.4M |
Cap table
Built by 6ix from Unipharma Co., Ltd.’s releases
- Common shares
- 35,501,000
- Fully diluted
- 35,501,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 35,501,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 35,501,000 |
Log in to ask 6ix AI your own questions about Unipharma Co., Ltd.